Chemomab Therapeutics Ltd. Proceeds from Stock Options Exercised
Chemomab Therapeutics Ltd. (CMMB) reported Proceeds from Stock Options Exercised of $12.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-03-23
- Chemomab Therapeutics Ltd. proceeds from stock options exercised for the quarter ending 2022-12-31 was $82.00K, a 720.00% increase year-over-year.
- Chemomab Therapeutics Ltd. proceeds from stock options exercised for the quarter ending 2022-09-30 was $39.00K.
- Chemomab Therapeutics Ltd. proceeds from stock options exercised for the quarter ending 2021-12-31 was $10.00K.
- Chemomab Therapeutics Ltd. proceeds from stock options exercised for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2025-12-31 | $12.00K 20-F · filed 2026-03-23 | |||
| 2025-06-30 | $2.00K 6-K · filed 2025-08-14 | |||
| 2024-12-31 | $0.00 20-F · filed 2026-03-23 | |||
| 2024-06-30 | $0.00 6-K · filed 2025-08-14 | |||
| 2023-12-31 | $0.00 20-F · filed 2026-03-23 | |||
| 2023-06-30 | $0.00 6-K · filed 2023-08-14 | |||
| 2022-12-31 | $82.00K derived: 20-F 12 month − 10-Q 9 month · filed 2025-04-04 | $121.00K derived: sum of 2 quarters · filed 2025-04-04 | $143.00K 20-F · filed 2025-04-04 | |
| 2022-09-30 | $39.00K derived: 10-Q 9 month − 6-K 6 month · filed 2022-11-10 | $61.00K 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | $22.00K 6-K · filed 2023-08-14 | |||
| 2021-12-31 | $10.00K derived: 20-F 12 month − 10-Q 9 month · filed 2024-03-28 | $10.00K derived: sum of 2 quarters · filed 2024-03-28 | $10.00K 20-F · filed 2024-03-28 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-12 | |||
| 2020-09-30 | $562.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $687.00K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $125.00K 10-Q · filed 2021-08-13 |